Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Interleukin 10 receptor beta (IL-10Rβ), also known as IL10RB, is a subunit of the interleukin-10 receptor complex and belongs to the class II cytokine receptor family. It acts as an accessory chain essential for the active interleukin-10 (IL-10) receptor complex and is required for signal transduction by several cytokines, including IL-10, IL-22, IL-26, and type III interferons. It plays a crucial role in regulating immune responses, particularly in suppressing pro-inflammatory signals in mucosal tissues. Defects or mutations can lead to severe inflammatory bowel disease.
Agonism or antagonism of IL-10, IL-22, IL-26, or Type III interferon signaling via modulation of receptor complex formation and downstream JAK/STAT pathway activation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Interleukin 10 Receptor Beta (IL10RB).